However, one study reported an improved therapeutic response to anti-PD-L1 blockade by augmenting tumor sensitivity to anti-PD-L1 therapy, thus resulting in prolonged survival in mice treated with F. nucleatum [154]. This evidence concerns the gene CD274 and neoplasm.